| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.066 | 0.8 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.033 | 0.8 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0095 | 0.8 |